Trials / Active Not Recruiting
Active Not RecruitingNCT06572982
Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients
Extension Study, Pilot, Single-arm, Compassionate Use of Hikma Azacitidine 300 mg Film Coated Tablets Test Product for the Acute Myeloid Leukaemia (AML) Patients Who Completed Hikma Bioequivalence Study With Protocol Number: HIK-AZA-2023-01
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Hikma Pharmaceuticals LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Extension study, pilot, single-arm, compassionate use of Hikma Azacitidine 300 mg Film coated tablets test product for the Acute Myeloid Leukaemia (AML) patients who completed Hikma bioequivalence study with protocol number: HIK-AZA-2023-01
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azacitidine | 300 mg Film coated tablets |
Timeline
- Start date
- 2025-04-29
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2024-08-27
- Last updated
- 2026-01-14
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT06572982. Inclusion in this directory is not an endorsement.